Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+23.6%
5Y CAGR+16.5%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+23.6%/yr
vs +12.7%/yr prior
5Y CAGR
+16.5%/yr
Recent acceleration
Acceleration
+10.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $748.43M | +12.7% |
| 2024 | $664.16M | +39.6% |
| 2023 | $475.89M | +20.0% |
| 2022 | $396.47M | +9.9% |
| 2021 | $360.70M | +3.6% |
| 2020 | $348.29M | +15.7% |
| 2019 | $300.98M | +22.3% |
| 2018 | $246.03M | +58.1% |
| 2017 | $155.65M | +96.4% |
| 2016 | $79.26M | - |